Onco Life Hospitals

Blood cancer is not a single disease. Leukaemia, lymphoma, and myeloma are distinct conditions with different biology, different staging systems, and different treatment protocols. A blood cancer specialist in Mumbai who knows the difference between acute myeloid leukaemia and chronic lymphocytic leukaemia, and who applies the right treatment protocol from the first consultation, is not the same as a general oncologist who manages occasional haematological cases alongside solid tumours. Finding that specialist, and finding access to them without a weeks-long wait, is the challenge most Mumbai families face at diagnosis.

Onco-Life Cancer Centre's haemato-oncology team provides specialist blood cancer care with expert diagnosis, molecular profiling, and personalised treatment planning for all blood cancer types. Our centres at Talegaon and Wagholi (Pune) are accessible from Mumbai in 75 to 90 minutes via the Mumbai-Pune Expressway. We treat leukaemia, lymphoma, myeloma, myelodysplastic syndromes, and related blood disorders in a dedicated oncology setting with a NABH-accredited care standard and a Tumour Board that reviews every patient before treatment begins.

Why Mumbai Patients Choose Onco-Life for Blood Cancer Treatment

Haemato-Oncology Expertise, Not General Chemotherapy

Blood cancers behave differently from solid tumours. They are staged differently, treated with different drug classes, and monitored with different markers. CML managed with a tyrosine kinase inhibitor requires very different expertise and follow-up from DLBCL treated with R-CHOP immunochemotherapy. Acute leukaemias require rapid action and induction protocols that must begin within days of diagnosis. Our haemato-oncologists work specifically in this field. They interpret bone marrow biopsy results, review cytogenetics and molecular markers, and select treatment protocols based on each patient’s specific blood cancer type, subtype, and risk profile.

Accessible from Mumbai in Under 90 Minutes

Our Talegaon centre is 70 to 75 km from Mumbai via the Expressway, about 75 to 90 minutes by car from most parts of the city. For blood cancer patients who require regular chemotherapy infusions over several months, the proximity matters practically. Many Mumbai patients drive to Talegaon for daycare chemotherapy infusions and return home the same day. For patients who find the commute difficult on infusion days, our team can arrange coordination to make the trips manageable.

NABH Accreditation and Specialised Haematology Facilities

Onco-Life holds three NABH (National Accreditation Board for Hospitals and Healthcare Providers) accreditations. For blood cancer patients specifically, our facilities include dedicated chemotherapy and targeted therapy daycare infusion units, on-site digital pathology for bone marrow biopsy and blood film analysis, PET-CT Scan for lymphoma staging and restaging, and a Virtual Tumour Board for every patient. We are a National Cancer Grid member hospital, which means our treatment protocols are aligned with Tata Memorial Centre.

All Blood Cancer Types Treated

Onco-Life treats the full range of haematological malignancies:

  • Acute leukaemias: Acute Myeloid Leukaemia (AML) and Acute Lymphoblastic Leukaemia (ALL)
  • Chronic leukaemias: Chronic Myeloid Leukaemia (CML) and Chronic Lymphocytic Leukaemia (CLL)
  • Hodgkin Lymphoma and Non-Hodgkin Lymphoma (including DLBCL, follicular lymphoma, mantle cell lymphoma, T-cell lymphomas)
  • Multiple Myeloma and related plasma cell disorders
  • Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN)
  • Aplastic anaemia and other bone marrow failure syndromes

Blood Cancer Treatment Cost in Mumbai

Blood cancer treatment cost in Mumbai varies significantly by cancer type, stage, and treatment regimen. At major private hospitals in the city, a single chemotherapy cycle for leukaemia or lymphoma can range from Rs 30,000 to Rs 1,50,000 depending on the drug protocol. Targeted therapy for CML (imatinib, dasatinib, or ponatinib) involves ongoing monthly medication costs of Rs 20,000 to Rs 1,00,000 depending on the drug and whether a generic is available. Rituximab-based immunochemotherapy for B-cell lymphoma adds significant cost per cycle. Bone marrow transplant, where indicated, is a major cost item at private hospitals.

At Onco-Life, blood cancer treatment costs are transparent. For self-paying patients, we provide a written cost estimate before treatment begins, broken down by treatment phase. Eligible patients under MJPJAY and PM-JAY may have chemotherapy, targeted therapy, and related packages covered at no cost. Call us with your diagnosis and specific blood cancer type and we will outline the expected costs and any scheme coverage before your first visit.

Comprehensive Blood Cancer Treatment at Onco-Life

Clinical Haematology: Diagnosis and Molecular Profiling

Accurate blood cancer diagnosis requires more than a blood count and a biopsy report. It requires bone marrow biopsy and aspiration, cytogenetic analysis (karyotype), FISH testing for specific chromosomal abnormalities (BCR-ABL for CML, JAK2 for MPNs), immunohistochemistry for lymphoma subtyping, and in many cases next-generation sequencing for mutation profiling. The treatment recommendation for blood cancer depends directly on this diagnostic workup. Our haemato-oncologists review the full diagnostic panel before any treatment protocol is selected.

Medical Oncology: Chemotherapy and Targeted Therapy

Our medical oncologists administer blood cancer treatment regimens that include:
  • Induction and consolidation chemotherapy for acute leukaemias (7+3, HiDAC, hyper-CVAD, and related protocols)
  • Tyrosine kinase inhibitors for CML: imatinib (first generation), dasatinib and nilotinib (second generation), and ponatinib for T315I-mutant disease
  • BCL-2 inhibitor therapy: venetoclax for CLL and AML in eligible patients
  • BTK inhibitors: ibrutinib and acalabrutinib for CLL and mantle cell lymphoma
  • CHOP and R-CHOP based regimens for aggressive and indolent lymphomas
  • ABVD and BEACOPP for Hodgkin Lymphoma
  • Bortezomib, lenalidomide, and dexamethasone-based protocols for multiple myeloma
All regimens are administered in our daycare infusion units. Dose adjustments and toxicity management are made at every cycle based on blood count results and clinical assessment.

Immunotherapy and Biological Agents

Biological therapy has changed blood cancer management significantly over the past decade. Rituximab and obinutuzumab for CD20-positive B-cell malignancies, daratumumab for myeloma, brentuximab for Hodgkin Lymphoma and ALCL, and checkpoint inhibitors for relapsed or refractory Hodgkin Lymphoma are among the agents our medical oncologists prescribe and administer. Treatment selection is based on the patient’s specific disease subtype, prior treatment history, performance status, and response to previous therapy.

PET-CT Scan for Lymphoma Staging and Restaging

PET-CT Scan is essential in lymphoma management. It provides metabolic staging before treatment begins, interim response assessment after two to four cycles of chemotherapy, and end-of-treatment restaging to confirm complete response or identify residual disease requiring further treatment. For Mumbai patients, PET-CT Scan is available at our Talegaon and Wagholi centres, with results reviewed directly by the treating haemato-oncologist rather than sent to a separate facility for interpretation.

Meet Our Blood Cancer Specialist Team

To consult a blood cancer doctor in Mumbai, visit our specialist page or contact our team to schedule a consultation.

Dr. Adwaita A. Gore

MBBS, DNB (Med), DNB (Oncology), ESMO-Certified, Haemato-Oncologist

Consultant Medical & Haemato-Oncologist

Onco-Life Cancer Centre, Chiplun Director & Partner – Oncology Care Associates LLP

Dr. Siddhesh Tryambake

M.B.B.S., M.D., D.N.B., DrNB

Consultant Clinical & Radiation Oncologist

Onco-Life Cancer Centre, Satara & T.G.H. Onco-Life Cancer Centre, Pune

Your Blood Cancer Care Journey at Onco-Life

Step 1: Initial Consultation and History Review

You meet with our haemato-oncologist who reviews your blood counts, bone marrow biopsy, cytogenetics, molecular test results, and imaging. We explain your specific diagnosis clearly: the type of blood cancer, the risk category, and what the findings mean for your treatment options. We answer every question.

Step 2: Complete Diagnostic Workup

If additional diagnostic tests are needed, including repeat bone marrow biopsy, FISH testing, next-generation sequencing, PET-CT Scan for lymphoma staging, or serum protein electrophoresis for myeloma, we arrange these on-site. Complete staging takes 7 to 10 days in most cases and is necessary before the treatment protocol is confirmed.

Step 3: Treatment Plan Confirmed at Tumour Board

Your case is reviewed at the Tumour Board. The treatment protocol, its sequencing, expected response monitoring schedule, and the plan if first-line treatment fails are all agreed before you begin. We explain the full plan, the likely side effects, and the monitoring schedule before you consent to proceed.

Step 4: Treatment and Response Monitoring

Treatment is administered at Onco-Life Talegaon or Wagholi. Blood counts, bone marrow responses, molecular markers (such as BCR-ABL PCR for CML), and PET-CT interim assessments are scheduled at appropriate intervals. Our team reviews results at every cycle and adjusts the protocol where the clinical situation requires it.

Step 5: Remission and Long-Term Follow-Up

After achieving remission or completing the active treatment phase, structured surveillance continues. For CML patients on long-term TKI therapy, molecular response monitoring continues indefinitely. For lymphoma patients in complete remission, regular clinical review and imaging continue for at least two years. For myeloma patients, maintenance therapy and M-protein monitoring are managed over the long term. We remain your clinical team throughout.

Why Choose Onco-Life for Blood Cancer Treatment in Mumbai?

Mumbai has hospitals with haematology departments. Onco-Life is a dedicated blood cancer hospital in Mumbai where specialists focus exclusively on cancer. The difference matters when choosing the best blood cancer hospital in Mumbai:

  • ESMO-certified Haemato-Oncologist on the team
  • Harvard HMX certified precision oncology approach for molecular profiling
  • All blood cancer types treated: leukaemia, lymphoma, myeloma, MDS, MPN
  • Full diagnostic workup on-site: bone marrow biopsy, cytogenetics, PET-CT Scan
  • Daycare infusion units for chemotherapy and targeted therapy
  • Tumour Board review before every treatment plan is confirmed
  • 3 NABH accreditations
  • National Cancer Grid member, protocols aligned with Tata Memorial Centre
  • Transparent treatment costs with written estimate before you begin
  • Accessible from Mumbai in 75 to 90 minutes via the Expressway

Government Scheme Coverage for Blood Cancer Treatment

Mumbai patients who hold an MJPJAY (Mahatma Jyotiba Phule Jan Arogya Yojana) or PM-JAY (Ayushman Bharat) card may have blood cancer chemotherapy and related treatment packages covered at no out-of-pocket cost at Onco-Life. CGHS and ECHS beneficiaries are also accepted. Our Arogya Mitra coordinators check your eligibility and manage all pre-authorisation before treatment begins. Call us with your scheme details and we will confirm coverage for your specific diagnosis before you travel.

Accessing Onco-Life Cancer Centre from Mumbai

Add the map here for Mumbai location for treatment like this

Talegaon (Nearest Centre to Mumbai – 75 to 90 Minutes)

Our Talegaon centre is the closest Onco-Life facility for Mumbai patients. Via the Mumbai-Pune Expressway, most patients reach us in 75 to 90 minutes. The centre offers full blood cancer services: diagnostic haematology, PET-CT Scan, chemotherapy and targeted therapy daycare, and Tumour Board review. Many patients from Mumbai travel for regular infusion days and return home the same afternoon.

Wagholi, Pune (approximately 90 to 105 minutes from Mumbai)

Our Wagholi centre near Pune is accessible by car or by train to Pune station followed by a short cab ride. PET-CT Scan, medical oncology, and full diagnostic services are available here. Patients from parts of Mumbai who find the Pune route more practical can access blood cancer services at this centre.

Book Your Consultation Today

Blood cancer requires timely care. Onco-Life’s haemato-oncology team offers fast access to expert consultation and treatment, helping you avoid long waiting times and start care without delay.

Ready to take the next step?

  • Call Talegaon (Nearest to Mumbai): 8128124067, 8128123067
  • Call Pune / Wagholi: 8128124067, 8128123067
  • Call Satara: 02162-350063, 7769004343, 7030362222
  • Call Chiplun: 7378958000, 9404240762
  • Book Online: https://oncolifehospitals.com/book-doctor-appointment/
  • Telemedicine Consultation: Speak with a blood cancer specialist online

We are here for you. Specialist blood cancer care is accessible from Mumbai. Let us help you get the right diagnosis and the right treatment plan in place.